A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Aclaris Therapeutics Inc’s current trading price is -63.37% away from its 52-week high, while its distance from the 52-week low is 254.12%. The stock’s price range for this time frame has been between $0.59 and $5.70. The trading volume of the company’s shares in the Healthcare reached around 1.26 million for the day, which was evidently higher than the average daily volume of 0.48 million over the last three months.
Aclaris Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $5.70 on 11/06/23, and the lowest price during that time was $0.59, recorded on 11/13/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Aclaris Therapeutics Inc (ACRS) has experienced a quarterly rise of 68.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 172.18M and boasts a workforce of 91 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.25, with a change in price of +0.97. Similarly, Aclaris Therapeutics Inc recorded 704,410 in trading volume during the last 100 days, posting a change of +86.61%.
How ACRS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ACRS stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
ACRS Stock Stochastic Average
Aclaris Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 96.04%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 96.04%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 90.46% and 86.42%, respectively.
ACRS Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 99.05%.However, over the last six months, we can see a weaker performance of 53.68%. Over the last 30 days, the price of ACRS has fallen by 75.63%. And in the last five days, it has surged by 23.67%.
